Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALGORAE PHARMACEUTICALS LIMITED Director's Dealing 2014

Mar 31, 2014

64249_rns_2014-03-31_ae0dcd8f-b9c9-4882-875d-d47ffe8a4c70.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity Living Cell Technologies Limited
ABN 14 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Andrea Louise Grant
Date of last notice 24 January 2013
Date that director ceased to be director 1 April 2014

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

250,000 unlisted options exercisable at $0.10 each and expiring 23/12/2017

250,000 unlisted options exercisable at $0.10 each and expiring 23/12/2018

  • See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of securities interest Note: Provide details of the circumstances giving rise to the relevant interest N/A

Part 3 – Director’s interests in contracts

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to
which interest relates
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002